Literature DB >> 25247617

Diagnostic pitfalls of drug-induced immune hemolytic anemia.

Abdulgabar Salama1, Beate Mayer2.   

Abstract

Immune hemolytic anemia (IHA) is a rare complication of drug administration. However, its true incidence remains obscure, as there are a number of factors that may lead to misdiagnosis. The clinical and serologic pictures are variable, and there is a great deal of unawareness that certain drugs can cause IHA. Furthermore, serologic results can be easily misinterpreted, resulting in a wrong diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25247617

Source DB:  PubMed          Journal:  Immunohematology        ISSN: 0894-203X


  4 in total

1.  Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.

Authors:  Sandeep Kumar; Rohit Bansal; Priya Bansal; Rajinder Kumar Dhamija; Dnb Neurology
Journal:  Perm J       Date:  2019-12-18

Review 2.  Clinically and/or Serologically Misleading Findings Surrounding Immune Haemolytic Anaemias.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

3.  Variability of Findings in Drug-Induced Immune Haemolytic Anaemia: Experience over 20 Years in a Single Centre.

Authors:  Beate Mayer; Thilo Bartolmäs; Salih Yürek; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-09-09       Impact factor: 3.747

Review 4.  Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.

Authors:  Hans Benno Leicht; Elke Weinig; Beate Mayer; Johannes Viebahn; Andreas Geier; Monika Rau
Journal:  BMC Pharmacol Toxicol       Date:  2018-10-25       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.